ECE2020 Audio ePoster Presentations Diabetes, Obesity, Metabolism and Nutrition (285 abstracts)
The icone study’: Multicenter evaluation of the impact of contour next one and contour diabetes app on self-management and adherence in insulin-treated patients with diabetes type 1 or 2
Diego Fernandez-Garcia 1 , Eva Aguilera Hurtado 2 , Alfonso Arranz Martin 3 , Beatriz Gonzalez Aguilera 4 , Blanca Gonzalez Jauregui 5 , Edelmiro Luis Menendez Torre 6 , Rebeca Reyes Garcia 7 , Alfonso Soto Gonzalez 8 , Cristina Tejera Perez 9 , Beatriz Fernandez-Tresguerres 10 & Thorsten Petruschke 10
1Xanit Hospital, Benalmádena, Spain; 2Hospital Germans Trias i Pujol, Badalona, Spain; 3Hospital de La Princesa, Madrid, Spain; 4hospital universitario virgen macarena, Sevilla, Spain; 5Hospital Universitario Cruces, Barakaldo, Spain; 6Central University Hospital of Asturias, Oviedo, Spain; 7Torrecárdenas Hospital, Almería, Spain; 8Hospital Universitario A Coruña, A Coruña, Spain; 9Hospital Arquitecto Marcide, Ferrol, Spain; 10Ascensia Diabetes Care Deutschland GmbH, Leverkusen, Germany
Objectives: The primary objective was to determine if the use of Contour Next One (CNO) with Contour Diabetes app (APP) was associated with improved self-management using the Summary of Diabetes Self-Care Activities questionnaire (SDSCA). A secondary objective was to establish if CNO and APP together had impact on adherence to self-monitoring blood glucose (BG), indicated by frequency of BG readings and hypoglycemic events. Other secondary objectives were to observe a possible change in HbA1c, patient empowerment and quality of life. Besides satisfaction with the CNO and APP was assessed.
Material and Methods: prospective, observational-study in nine clinical practices in Spain. 87 Multiple dose Insulin-treated patients with either type 1 or 2 diabetes mellitus were enrolled. Patients used already the CNO but had not included the APP yet. Patients had a recent HbA1c test and previous 3 month glucose data. Each patient had two on site visits at 0 days (visit 1) and 90 days (visit 2).
Results: 84 patients were eligible for the analysis (88.1% type 1; 11.9% type 2). Statistical significant differences were observed in the SDSCA scores for General diet and Specific diet questions with an increase of 1 day of median between visits. Besides a significant increase was observed in the total number of BG readingsbetween visits [median 259.1 vs 276.1] and in the number of readings per day [median 2.9 vs 3.1]. Furthermore, the % of BG values in range was significantly increased in visit 2 [median 51.0% vs 54.0%] and the average of BG values decreased [median 169.0 vs 161.5 mg/dl ]. Consequently a significant decrease in the HbA1c value was observed between visits [mean 7.6% vs 7.38%]. On the other hand, there were no significant differences in the % of hypo/hyperglycemic episodes although a trend was observed in visit 2 toward a decrease in episodes >250 mg/dl. No significant differences were found in the questionnaires related to Quality of life and empowerment. The overall satisfaction of patients and Health Care Practitioners with CNO and the APP scored high.
Conclusion: The effects of the joint use of CNO and the APP are already observed after a relative short period in multiple dose insulin-treated patients with diabetes type 1 or 2. The CNO with the APP helped the patients to have a better glycemic control by means of improving their adherence to self-monitoring and diet self-management, all without reducing their quality of life or empowerment.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more